Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Purunao Biotechnology is a leading Chinese synthetic biology company focused on the development and large-scale production of high-value natural products and functional ingredients. The company specializes in the biosynthesis of human milk oligosaccharides (HMOs), such as 2'-fucosyllactose (2'-FL), using proprietary metabolic engineering and microbial fermentation technologies. By establishing robust microbial "cell factories," Purunao provides sustainable and cost-effective nutritional solutions for the global infant formula, dietary supplement, and pharmaceutical industries. Headquartered in Shanghai, the company has successfully transitioned from R&D to commercial-scale manufacturing, receiving regulatory approvals for its primary products. The firm is backed by prominent venture capital firms and continues to expand its portfolio of specialty bio-based nutrients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Purunao Biotechnology.